Literature DB >> 12943869

Impact of pathogen burden in patients with coronary artery disease in relation to systemic inflammation and variation in genes encoding cytokines.

Jean Louis Georges1, Hans J Rupprecht, Stefan Blankenberg, Odette Poirier, Christoph Bickel, Gerd Hafner, Viviane Nicaud, Jürgen Meyer, François Cambien, Laurence Tiret.   

Abstract

The number of infectious pathogens to which an individual has been exposed (pathogen burden) has been linked to the development and the prognosis of coronary artery disease (CAD). The interaction among infection, genetic host susceptibility, and CAD remains unclear. This study was aimed at evaluating the modulation of the association between CAD and pathogen burden, by serum levels of inflammatory markers and polymorphisms of the interleukin (IL)-6 and tumor necrosis factor (TNF)-alpha genes. Immmunoglobulin (Ig) G or IgA antibodies to 8 pathogens were determined in 991 patients with CAD and 333 control subjects. Serum levels of high-sensitivity C-reactive protein, fibrinogen, IL-6, and TNF-alpha were also measured. All subjects were genotyped for the IL-6/G-174C, the TNF/C-851T, and the TNF/G-308A polymorphisms. Analysis of single pathogens demonstrated a positive relation to the presence of CAD for some (Chlamydia pneumoniae, cytomegalovirus, Helicobacter pylori, and herpes virus simplex type 1), but not all pathogens. A strong association between increasing pathogen burden and CAD was confirmed, even after adjustment for risk factors. The prevalence of a high pathogen burden (>/=4 pathogens) was 50% in patients and 21% in controls (p <0.0001). A high pathogen burden was associated with decreased high-density lipoprotein cholesterol levels (p <0.001). The association between CAD and pathogen burden was modulated by the IL6/G-174C polymorphism, the odds ratio being higher in heterozygotes than in both types of homozygotes (p <0.05). This interaction appeared to be mediated by variations in serum IL-6 levels. No such interaction was detected with any of the 2 TNF-alpha polymorphisms.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12943869     DOI: 10.1016/s0002-9149(03)00717-3

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  38 in total

1.  Cytomegalovirus infection and coronary heart disease risk: a meta-analysis.

Authors:  Ya-Nan Ji; Li An; Ping Zhan; Xiao-Hu Chen
Journal:  Mol Biol Rep       Date:  2012-02-04       Impact factor: 2.316

Review 2.  Coronary heart disease and polymorphisms in genes affecting lipid metabolism and inflammation.

Authors:  François Cambien
Journal:  Curr Atheroscler Rep       Date:  2005-05       Impact factor: 5.113

3.  Determinants of lumbar artery occlusion among patients with sciatica: a three-year follow-up with magnetic resonance angiography.

Authors:  Jaro Karppinen; Mauno Kurunlahti; Simo Taimela; Marianne Haapea; Heikki Vanharanta; Osmo Tervonen
Journal:  Eur Spine J       Date:  2005-02-19       Impact factor: 3.134

Review 4.  Socioeconomic position and inflammatory and immune biomarkers of cardiovascular disease: applications to the Panel Study of Income Dynamics.

Authors:  Allison E Aiello; George A Kaplan
Journal:  Biodemography Soc Biol       Date:  2009

5.  Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways.

Authors:  Martha L Slattery; Roger K Wolff; Karen Curtin; Frank Fitzpatrick; Jennifer Herrick; John D Potter; Bette J Caan; Wade S Samowitz
Journal:  Mutat Res       Date:  2008-10-15       Impact factor: 2.433

6.  The influence of persistent pathogens on circulating levels of inflammatory markers: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis.

Authors:  Aydin Nazmi; Ana V Diez-Roux; Nancy S Jenny; Michael Y Tsai; Moyses Szklo; Allison E Aiello
Journal:  BMC Public Health       Date:  2010-11-17       Impact factor: 3.295

7.  Association Between Small Intestinal Bacterial Overgrowth by Glucose Breath Test and Coronary Artery Disease.

Authors:  Andre Fialho; Andrea Fialho; Gursimran Kochhar; Aldo L Schenone; Prashanti Thota; Arthur J McCullough; Bo Shen
Journal:  Dig Dis Sci       Date:  2017-11-06       Impact factor: 3.199

8.  Clinical efficiency of Helicobacter pylori eradication in the treatment of patients with acute central serous chorioretinopathy.

Authors:  Olesya Zavoloka; Pavlo Bezditko; Irina Lahorzhevska; Darya Zubkova; Yevgeniya Ilyina
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-03-16       Impact factor: 3.117

Review 9.  Infectious burden and atherosclerosis: A clinical issue.

Authors:  Rosa Sessa; Marisa Di Pietro; Simone Filardo; Ombretta Turriziani
Journal:  World J Clin Cases       Date:  2014-07-16       Impact factor: 1.337

10.  Association between the TNF-α G-308A polymorphism and risk of ischemic heart disease: a meta-analysis.

Authors:  Jiarong Wang; Yazhou He; Yang Yang; Tiange Song; Nan Chen; Yanhong Zhou
Journal:  Int J Clin Exp Med       Date:  2015-06-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.